Press Release – New York, NY – December 9, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented Virax Biolabs Group Limited (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, in its recently completed $5 million private placement.
The SRFC team was led by partners Greg Sichenzia and Barrett DiPaolo, with associate Brady Berman.
H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the offering. The H.C. Wainwright team was led by Noam Rubinstein, Ilya Kravets and John Cordio.